What were the primary and secondary end points in the ISAR-TRIPLE study?
The primary end point of the ISAR-TRIPLE study was a composite of death, myocardial infarction, definite stent thrombosis, stroke, or Thrombolysis In Myocardial Infarction major bleeding at 9 months. The secondary end points included the combined ischemic end point of cardiac death, myocardial infarction, definite stent thrombosis, and Thrombolysis In Myocardial Infarction major bleeding, and the secondary bleeding end point of Thrombolysis In Myocardial Infarction major bleeding.